Loading...

Anne Marsh

Title(s)HS Assoc Clinical Professor, Pediatrics
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Wisconsin School of Medicine and Public Health, Madison, WIMD05/2007
    University of Wisconsin Hospital and Clinics, Madison, WI06/2010Pediatrics
    Children's Hospital & Research Center Oakland, Oakland, CA06/2013Pediatric Hematology/Oncology

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cabana MD, Kanter J, Marsh AM, Treadwell MJ, Rowland M, Stemmler P, Bardach NS. Barriers to Pediatric Sickle Cell Disease Guideline Recommendations. Glob Pediatr Health. 2019; 6:2333794X19847026. PMID: 31106244.
      View in: PubMed
    2. Fearon A, Marsh A, Kim J, Treadwell M. Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management. Pediatr Blood Cancer. 2019 Feb; 66(2):e27535. PMID: 30387290.
      View in: PubMed
    3. Agrawal AK, Robertson S, Litwin L, Tringale E, Treadwell M, Hoppe C, Marsh A. Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease. Pediatr Blood Cancer. 2019 Feb; 66(2):e27525. PMID: 30362236.
      View in: PubMed
    4. Kelly S, Quirolo K, Marsh A, Neumayr L, Garcia A, Custer B. Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature. Transfusion. 2016 11; 56(11):2877-2888. PMID: 27759170.
      View in: PubMed
    5. Lal A, Patterson L, Goldrich A, Marsh A. Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia. Pediatr Blood Cancer. 2015 May; 62(5):912-4. PMID: 25683629.
      View in: PubMed
    6. Marsh A, Schiffelers R, Kuypers F, Larkin S, Gildengorin G, van Solinge W, Hoppe C. Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease. Br J Haematol. 2015 Jan; 168(1):135-8. PMID: 25196812.
      View in: PubMed
    7. Treadwell MJ, Bell M, Leibovich SA, Barreda F, Marsh A, Gildengorin G, Morris CR. A Quality Improvement Initiative to Improve Emergency Department Care for Pediatric Patients with Sickle Cell Disease. J Clin Outcomes Manag. 2014 Feb; 21(2):62-70. PMID: 26412961.
      View in: PubMed
    8. Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer. 2014 Mar; 61(3):567. PMID: 24108577.
      View in: PubMed
    9. Marsh AM, Lo L, Cohen RA, Feusner JH. Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP. Pediatr Blood Cancer. 2012 Nov; 59(5):939-40. PMID: 22492703.
      View in: PubMed
    10. Kuypers FA, Marsh AM. Research in athletes with sickle cell trait: just do it. J Appl Physiol (1985). 2012 May; 112(9):1433. PMID: 22362400.
      View in: PubMed